首页> 美国卫生研究院文献>International Journal of Endocrinology >A Study on Central Lymph Node Metastasis in 543 cN0 Papillary Thyroid Carcinoma Patients
【2h】

A Study on Central Lymph Node Metastasis in 543 cN0 Papillary Thyroid Carcinoma Patients

机译:543例cN0乳头状甲状腺癌患者中心淋巴结转移的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Papillary thyroid carcinoma (PTC) with central lymph node metastases (CLNMs) is common. The objective of this study was to investigate the incidence and risk factors of lymph node metastasis patients with PTC. Patients and Methods. Between January 2013 and February 2015, a retrospective study of 543 patients with PTC undergoing hemithyroidectomy or total thyroidectomy with routine central lymph node dissection (CLND) was analyzed. Clinicopathologic risk factors for CLNM were studied using univariate and multivariate analysis by SPSS 22.0 software. Results. The incidence of CLNMs in PTC patients was 38.1% (207/543). In the multivariate analysis, male gender (p < 0.001, OR: 1.984), age <45 years (p < 0.001, OR: 1.934), bilaterality (p = 0.006, OR: 1.585), tumor size ≥0.25 cm (p = 0.001, OR: 7.655), and external extension (p = 0.001, OR: 7.579) were independent risk factors of CLNMs. Furthermore, in PTC patients with tumor size <0.25 cm, all 7 males and 21 patients with unilaterality were not found to have CLNMs. Conclusions. CLNMs are prevalent in the PTC patients with the following risk factors: male gender, age <45 years, bilaterality, tumor size ≥0.25 cm, and external extension. PTC patients with tumor size <0.25 cm, male patients, and patients with unilateral lesion could be considered safe from CLNMs.
机译:背景。甲状腺乳头状癌(PTC)伴有中央淋巴结转移(CLNM)是常见的。这项研究的目的是调查PTC淋巴结转移患者的发病率和危险因素。患者和方法。在2013年1月至2015年2月之间,一项回顾性研究对543例行常规甲状腺中央淋巴结清扫术(CLND)的甲状腺切除术或全甲状腺切除术的PTC患者进行了分析。通过SPSS 22.0软件使用单因素和多因素分析研究了CLNM的临床病理危险因素。结果。 PTC患者的CLNMs发生率为38.1%(207/543)。在多变量分析中,男性(p <0.001,OR:1.984),年龄<45岁(p <0.001,OR:1.934),双边关系(p = 0.006,OR:1.585),肿瘤大小≥0.25cm(p = 0.001,OR:7.655)和外部扩展(p = 0.001,OR:7.579)是CLNM的独立危险因素。此外,在肿瘤尺寸<0.25 cm的PTC患者中,未发现所有7名男性和21名单侧患者均患有CLNM。结论。 CLNMs在PTC患者中普遍存在,具有以下风险因素:男性,年龄<45岁,双侧性,肿瘤大小≥0.25cm和外部扩展。肿瘤大小<0.25 cm的PTC患者,男性患者和单侧病变患者可被认为对CLNM安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号